Annovis Bio is down -9.6%, or -$1.06 to $10.03.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Largest borrow rate increases among liquid names
- Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
- Annovis Bio announces publication on buntanetap
- Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
- ANVS Earnings this Week: How Will it Perform?